I 
114TH CONGRESS 
1ST SESSION H. R. 1416 
To prevent application of sequestration to payment for certain physician- 
administered drugs under part B of the Medicare program in fiscal 
years 2016 and 2017, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 18, 2015 
Mrs. ELLMERS of North Carolina (for herself and Mr. ISRAEL) introduced the 
following bill; which was referred to the Committee on the Budget, and 
in addition to the Committees on Ways and Means and Energy and Com-
merce, for a period to be subsequently determined by the Speaker, in 
each case for consideration of such provisions as fall within the jurisdic-
tion of the committee concerned 
A BILL 
To prevent application of sequestration to payment for cer-
tain physician-administered drugs under part B of the 
Medicare program in fiscal years 2016 and 2017, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Cancer Patient Protec-
tion Act of 2015’’. 
VerDate Sep 11 2014 
04:18 Mar 19, 2015
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1416.IH
H1416
smartinez on DSK4TPTVN1PROD with BILLS
SEC. 2. PREVENTING APPLICATION OF SEQUESTRATION TO 
PAYMENT 
FOR 
PHYSICIAN-ADMINISTERED 
DRUGS UNDER PART B OF THE MEDICARE 
PROGRAM IN FISCAL YEARS 2016 AND 2017. 
(a) IN GENERAL.—Notwithstanding any other provi-
sion of law, any Presidential order issued after the date 
of the enactment of this Act under section 251A of the 
Balanced Budget and Emergency Deficit Control Act of 
1985 (2 U.S.C. 901a) for fiscal year 2016 or for fiscal 
year 2017 shall provide that no reduction is made with 
respect to payments for drugs and biologicals under sec-
tion 1847A of the Social Security Act (42 U.S.C. 1395w– 
4) to the extent that such payments are made based on 
the average sales price for such drugs and biologicals. 
(b) CONSTRUCTION.—Nothing in this section (other 
than subsection (d)) shall be construed as affecting any 
other payments under title XVIII of the Social Security 
Act or any other Act (other than under this section) or 
as requiring or authorizing the reduction of other pay-
ments, under such title or otherwise, by virtue of the appli-
cation of this section. 
(c) GAO STUDY OF SHIFT IN LOCATION OF CANCER 
CARE.—The Comptroller General of the United States 
shall conduct a study that examines the shift of cancer 
care from physician-run community cancer clinics to hos-
pitals and the consequences of this shift to costs to the 
VerDate Sep 11 2014 
04:18 Mar 19, 2015
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1416.IH
H1416
smartinez on DSK4TPTVN1PROD with BILLS
Federal Government and to Medicare beneficiaries for 
cancer care under the Medicare program. Not later than 
February 1, 2017, the Comptroller General shall submit 
a report to Congress on the results of such study. 
(d) IMPOSITION
OF BUDGET NEUTRALITY.—If a 
Presidential order described in subsection (a) is issued 
with respect to fiscal year 2016 and is also issued with 
respect to fiscal year 2024 (or with respect to fiscal year 
2017 and also issued with respect to fiscal year 2025), 
the amount of the aggregate payment reduction required 
under such an order with respect to fiscal year 2024 (or 
fiscal year 2025, respectfully) shall be increased by an 
amount equivalent to the amount of the payment increase 
resulting from the application of subsection (a) in fiscal 
year 2016 (or fiscal year 2017, respectively). 
Æ 
VerDate Sep 11 2014 
04:18 Mar 19, 2015
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H1416.IH
H1416
smartinez on DSK4TPTVN1PROD with BILLS